
Nick Tschernia, MD
481 posts

Nick Tschernia, MD
@NickTscherniaMD
Doctor of Hematology/Oncology • Physician-Scientist Early Investigator at NIH • Tweets are my own. He/him #Immunotherapy #CellTherapy #Cancer






I have questions for both sides on the Moderna/FDA story. (1) FDA/Vinay Prasad defenders: Even if you think Moderna should have used a higher dose comparator for people over 65, don't you think its wrong to deny an effective vaccine to people aged 50-64? (2) Moderna defenders: Don't you think Moderna should have compared to the best vaccine for people ages 65 and up? Bonus question: Are these questions that should result in the application not being reviewed, or issues the FDA should have grappled with in the review process? $MRNA $PFE







In response to these children's deaths, I've seen people refuse to believe they died from flu, suggest the children had comorbidities, or blamed parents for not seeking care. In 2016 my perfectly healthy 2yo woke up with a low-grade fever and died hours later. Flu can kill fast.








Dr. @emilyliangmd expertly presenting at #ASH25 the largest study to date diving into the use of anakinra for refractory/severe ICANS (n=101). We benchmark key clinical outcomes, and identify potential predictive biomarkers of anakinra efficacy. Prospective comparative studies critically needed! #CARTx #anakinra #CARTOX @OHSUNews



Bret & Heather Weinstein recommend Ivermectin and fasting over traditional Cancer treatments like Chemo and radiation. #Ivermectin #Fenbendazole #Cancercure


Ah yes, all those greedy physicians. You mean the one’s whose median salary is 350K? And the hospital CEOs whose median salary is 1.1MM? “Better to remain silent and be thought a fool than to speak and remove all doubt.” Instead of proving yourself to be wholly retarded, you could just choose to not post.




Scan results this morning. First time in several years, I’m headed into my appt blind, without having read or looked at my scans. The further out I get from my diagnosis, the more I’m convinced “what do patients want” is a moving target. I used to read my reports the second











New online! Neurological complications of CAR T cell therapy for cancers bit.ly/4eqkbCe
